Skip to main content
SleepCited

Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.

Marcos Lacasa, Jose Alegre-Martin, Ramon Sanmartin Sentañes, Luisa Varela-Sende, Joanna Jurek et al.
RCT Nutrients 2023 9 цитирований
PubMed DOI CC-BY PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D37960157'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Тип исследования
RCT
Размер выборки
65
Длительность
36 weeks
Вмешательство
Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Contro 4 capsules daily, each containing: beta-glucan 250 mg + vitamin D3 3.75 µg + vitamin B6 1.05 mg + zi
Препарат сравнения
Placebo
Направление эффекта
Positive
Риск систематической ошибки
Low

Abstract

This research aimed to examine the potential alleviative effects of beta-glucan administration on fatigue, unrefreshing sleep, anxiety/depression symptoms and health-related quality of life in ME/CFS. A 36-week unicenter, randomized, double-blind, placebo-controlled trial was conducted in 65 ME/CFS patients, who were randomly allocated to one of two arms to receive four capsules each one of 250 mg beta-glucan, 3.75 µg vitamin D3, 1.05 mg vitamin B6, and 7.5 mg zinc (n = 35), or matching placebo including only microcrystalline cellulose as an excipient (n = 30) once daily. The findings showed that the beta-glucan supplementation significantly improved cognitive fatigue (assessed with FIS-40 scores) after the 36-week treatment compared to the baseline (p = 0.0338). Taken together, this study presents the novel finding that yeast-derived beta-glucan may alleviate cognitive fatigue symptoms in ME/CFS. Thus, it offers valuable scientific insights into the potential use of yeast beta-glucan as a nutritional supplement and/or functional food to prevent or reduce cognitive dysfunction in patients with ME/CFS. Further interventions are warranted to validate these findings and also to delve deeper into the possible immunometabolic pathomechanisms of beta-glucans in ME/CFS.

Full Text

PDF
Loading PDF...

Figures

Tables

Table 5

SF-36 DomainsBaseline36-Weeksp-Values 1
Active arm (n = 29)
Physical functioning38.45 ± 20.4940.17 ± 22.500.8178
Physical role functioning6.03 ± 16.6610.34 ± 20.610.2020
Bodily pain15.93 ± 15.5820.90 ± 18.680.1468
General health perception22.76 ± 14.1821.90 ± 13.190.5683
Vitality12.24 ± 13.5316.55 ± 15.930.0526
Social role functioning32.33 ± 26.6336.64 ± 25.650.3344
Emotional role functioning34.48 ± 46.7028.74 ± 43.390.1695
Mental health status38.21 ± 21.1842.07 ± 22.690.1393
Placebo (n = 22)
Physical functioning39.32 ± 21.1738.18 ± 20.210.9243
Physical role functioning1.14 ± 5.334.55 ± 16.610.3287
Bodily pain20.14 ± 19.2223.73 ± 15.330.1089
General health perception25.32 ± 14.4927.36 ± 17.570.3225
Vitality17.27 ± 16.2415.23 ± 12.770.5847
Social role functioning30.68 ± 20.6842.05 ± 22.340.0131 *
Emotional role functioning33.33 ± 44.8437.88 ± 45.190.4797
Mental health status38.73 ± 23.1144.73 ± 20.010.1918

References

  1. Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology J. Clin. Med., 2020
  2. Gender differences in chronic fatigue syndrome Reumatol. Clin., 2016
  3. European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe Medicina, 2021
  4. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review Diagnostics, 2019
  5. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: All roads lead to Rome Br. J. Pharmacol., 2017
  6. Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: A community-based cross-sectional study from Spain BMC Public Health, 2019
  7. Chronic fatigue syndrome and quality of life Patient Relat. Outcome Meas., 2018
  8. The Conners Continuous Performance Test CPT3TM: Is it a reliable marker to predict neurocognitive dysfunction in Myalgic encephalomyelitis/chronic fatigue syndrome? Front. Psychol., 2023
  9. Prevalence of and risk factors for severe cognitive and sleep symptoms in ME/CFS and MS BMC Neurol., 2017
  10. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome J. Transl. Med., 2021
  11. Myalgic encephalomyelitis: International Consensus Criteria J. Intern. Med., 2011
  12. What’s in a name? Systemic exertion intolerance disease Lancet, 2015
  13. Cognitive Dysfunction in Chronic Fatigue Syndrome: A Review of Recent Evidence Curr. Rheumatol. Rep., 2016
  14. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome—A randomized, controlled, double-blind trial Clin. Nutr., 2016
  15. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: Disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS Neuroendocrinol. Lett., 2009
  16. Poor self-reported sleep quality and health-related quality of life in patients with chronic fatigue syndrome/myalgic encephalomyelitis J. Sleep Res., 2018
  17. Gut inflammation in chronic fatigue syndrome Nutr. Metab., 2010
  18. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome Gut Pathog., 2009
  19. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: Neuropsychological symptoms and sex comparisons J. Transl. Med., 2018
  20. Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: Implications for disease-related biomarker discovery Front. Immunol., 2023
  21. Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS Cell Host Microbe, 2023
  22. Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases Clin. Gastroenterol. Hepatol., 2021
  23. The role of the gut microbiome in cancer-related fatigue: Pilot study on epigenetic mechanisms Support. Care Cancer, 2021
  24. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters PLoS ONE, 2015
  25. Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study Diabetes Care, 2018
  26. beta-glucans: A potential source for maintaining gut microbiota and the immune system Front. Nutr., 2023
  27. In vitro fermentation of oat and barley derived beta-glucans by human faecal microbiota FEMS Microbiol. Ecol., 2008
  28. The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications J. Clin. Med., 2021
  29. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) Front. Immunol., 2021
  30. beta-glucan Salecan Improves Exercise Performance and Displays Anti-Fatigue Effects through Regulating Energy Metabolism and Oxidative Stress in Mice Nutrients, 2018
  31. Effects of Yeast (1,3)-(1,6)-Beta-Glucan on Severity of Upper Respiratory Tract Infections: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Subjects J. Am. Coll. Nutr., 2019
  32. A beta-Glucan-Based Dietary Fiber Reduces Mast Cell-Induced Hyperpermeability in Ileum From Patients With Crohn’s Disease and Control Subjects Inflamm. Bowel Dis., 2017
  33. Effects of beta-(1,3-1,6)-D-glucan on irritable bowel syndrome-related colonic hypersensitivity Biochem. Biophys. Res. Commun., 2012
  34. Effect of beta-glucan, inositol and digestive enzymes in GI symptoms of patients with IBS Eur. Rev. Med. Pharmacol. Sci., 2011
  35. Evaluation of the association between placental corticotrophin-releasing hormone and postpartum depressive symptoms Psychosom. Med., 2014
  36. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome Sci. Rep., 2017
  37. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group Ann. Intern. Med., 1994
  38. Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale Clin. Infect. Dis., 1994
  39. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research Psychiatry Res., 1989
  40. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population Gen. Hosp. Psychiatry, 2003
  41. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): An instrument for measuring clinical results Med. Clin., 1995
  42. Effects of oat beta-glucan on innate immunity and infection after exercise stress Med. Sci. Sport. Exerc., 2004
  43. Role of the gut-brain axis in energy and glucose metabolism Exp. Mol. Med., 2022
  44. The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights Nutrients, 2023
  45. Multi-’omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients Cell Host Microbe, 2023
  46. Central and Peripheral Fatigue in Physical Exercise Explained: A Narrative Review Int. J. Environ. Res. Public. Health, 2022
  47. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome JCI Insight, 2022
  48. Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2: More in Common Than Not? Chest, 2023
  49. High fibre breakfast cereals reduce fatigue Appetite, 2001
  50. Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial Int. J. Mol. Sci., 2016
  51. Effect of Oat beta-Glucan on Affective and Physical Feeling States in Healthy Adults: Evidence for Reduced Headache, Fatigue, Anxiety and Limb/Joint Pains Nutrients, 2021
  52. A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy J. Exp. Clin. Cancer Res., 2008
  53. Sleep depth and fatigue: Role of cellular inflammatory activation Brain Behav. Immun., 2011
  54. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials Molecules, 2019
  55. beta-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application J. Fungi, 2020
  56. The Microbiota-Gut-Brain Axis Physiol. Rev., 2019
  57. Three Different Types of beta-Glucans Enhance Cognition: The Role of the Gut-Brain Axis Front. Nutr., 2022

Used In Evidence Reviews

Similar Papers